Abstract P2-10-18: A study to evaluate the safety and efficacy of vosilasarm (EP0062), an oral SARM, as monotherapy and in combination with standard of care regimens in patients with relapsed locally advanced or metastatic AR+/HER2-/ER+ breast cancerJoyce O’Shaughnessy, Hyo S. Han, Noelia Martínez-Jáñez et al.|Clinical Cancer Research|2025Cited by 0